Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Peptides for Pharmacies: How to Prepare for BPC 157, Category 1 Changes & What to Do Now (Webinar) The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York 503A vs. 503B Compounding & FDA Regulations Guide Restore Health Consulting